Glenmark Therapeutics INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$31Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
886clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $31K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Dermatology $18K
Otolaryngology $2,159
Foot & Ankle Surgery $1,879
Pulmonary Disease $1,683
Podiatrist $1,074
Allergy $1,044

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Hilary Baldwin Brooklyn, NY Dermatology $4,780.00
Amy Spizuoco New York, NY Dermatology $4,416.00
Charles Andrews San Antonio, TX Pulmonary Disease $1,683.00
Gary Gross Dallas, TX Allergy $1,017.00
Bruce Prenner San Diego, CA Allergy & Immunology $872.00
Michael Wiederkehr Paramus, NJ Dermatology $600.00
Jonathan Weiss Snellville, GA Dermatology $330.00
Leon Kircik Lousiville, KY Dermatology $307.00
Zoe Draelos High Point, NC Dermatology $280.00
Hal Weitzbuch Calabasas, CA Dermatology $153.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.